Roche's Foundation Medicine gets FDA breakthrough device nod in latest designations

Roche's Foundation Medicine leads the latest group of FDA breakthrough designations, securing the regulatory privileges for an assay designed to detect circulating tumor DNA (ctDNA) in plasma.